PapersPMID:34323337
The effect of an orally-dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double-blind, randomised, placebo-controlled study.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 4 months
- Dose studied, every finding
- 450 mg per day across two 225 mg capsules, one at breakfast and one at dinner
What moved
How to read these marks →“After 16 weeks of treatment, the Gpp group had a significant reduction in total body weight, BMI, total fat mass and gynoid fat mass compared to the placebo group (p < 0.05) (Figure and Table 2).”
- Decreases fat mass
moderate
- Interests
- Industry funded
- Population
- Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); total body fat by dual-energy X-ray absorptiometry; placebo was maltodextrin in identical capsules
- Decreases body mass
moderate
- Interests
- Industry funded
- Population
- Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); placebo was maltodextrin in identical capsules
- Decreases body mass index
moderate
- Interests
- Industry funded
- Population
- Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); placebo was maltodextrin in identical capsules
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Overweight and class one obese men and women over 18 years, Brisbane Australia; ActivAMP G. pentaphyllum capsule supplement
- Participants
- 150
- Comparator
- placebo
- Duration
- 112 days
- Endpoints measured
- 31